Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial

Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial

Study objective: The objective of the study was to evaluate the safety and efficacy of remimazolam besylate versus propofol injection in patients undergoing colonoscopy.Design: A multicenter, randomized, non-inferiority, single-blind, parallel-controlled clinical trial.Setting: Operating room.Patien...

Full description

Bibliographic Details
Main Authors: Ximei Wang, Xiaolei Hu, Nianyue Bai, Lie Li, Min Zhang, Zhigang Cheng, Qulian Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pharmacology
Subjects:
remimazolam besylate
propofol
sedation
adverse
events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.900723/full

Similar Items

Similar Items